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The Rare Case of Streptococcus Pyogenes 
Pneumonia and Its Sequelae 
Fern Martin, MD and Gloria Francis, MD
InTroduCTIon
Group A Streptococcus (GAS) or Streptococcus pyogenes 
is an aerobic gram-positive coccus that causes a 
multitude of infections that range in severity. GAS most 
commonly infects the soft tissues, which results in 
infections such as cellulitis, erysipelas, necrotizing fasciitis 
and myositis. These deep soft tissue infections are also 
the most common source of GAS bacteremia. Other 
common infections caused by GAS include pharyngitis, 
rheumatic fever and glomerulonephritis.1 The lower 
respiratory tract is an uncommon site for GAS infection 
and it is the least common source of GAS bacteremia; 
however, in adults with GAS pneumonia, the incidence of 
bacteremia is 80 percent.2 Patients with a severe GAS 
infection can develop streptococcal toxic shock 
syndrome, which consists of GAS bacteremia in 
conjunction with shock and organ failure. Here we 
present a case of severe GAS pneumonia complicated by 
toxic shock syndrome and purpura fulminans, a rare 
complication of disseminated GAS infection.  
CaSE PrESEnTaTIon 
A 57-year-old male with a history of gastric adenocarcinoma 
status post partial gastrectomy presented with a two-day 
history of shortness of breath and chest tightness. He 
denied any associated fevers, cough, sputum production, 
pharyngitis, diarrhea or dysuria. In the emergency room, he 
was afebrile (although he had been taking acetaminophen-
oxycodone tablets every 4 to 6 hours for his chest pain) 
with a heart rate of 123 bpm, blood pressure 78/49 mmHg, 
respiratory rate 21-27 bpm, and pulse oximetry of 94% 
on a non-rebreather. Physical exam revealed right upper 
lobe rales, as well as egophony and sinus tachycardia. 
There was no evidence of pharyngeal erythema, exudates, 
or ulcers. Pertinent lab work on admission included a 
creatinine of 2.3 mg/dL and a lactate of 9.0 mmol/L. 
Computed tomography (CT) of his chest was consistent 
with pneumonia in the right upper lobe with patchy areas 
of consolidation in the right middle and lower lobes. The 
patient received ceftriaxone, azithromycin and five liters of 
normal saline. He was admitted to the medical intensive 
care unit (MICU) for severe sepsis secondary to community-
acquired pneumonia.
InvESTIgaTIonS and TrEaTMEnT 
After fluid resuscitation and antibiotic initiation, the 
patient’s vital signs improved to a heart rate of 102 bpm 
and blood pressure of 116/72 mmHg. On hospital day 2, 
the patient had a temperature of 103.1° F, heart rate 108 
bpm, blood pressure 91/60 mmHg, respiratory rate 35 
bpm, and pulse oximetry of 90% on a non-rebreather. The 
patient was intubated for acute hypoxic respiratory failure. 
His rapid influenza test was negative and gram stain from 
blood cultures revealed gram-positive cocci in chains. 
The team presumed that the patient had a Streptococcus 
species pneumonia with subsequent bacteremia. 
Over the next twelve hours, the patient continued to 
be hypotensive and a norepinephrine infusion was 
started. He subsequently developed acute oliguric renal 
failure, which required hemodialysis.  Blood cultures 
grew Streptococcus pyogenes, but despite appropriate 
intravenous (IV) antibiotics and vasopressors, the patient 
remained hypotensive and his lactate rose to 12.2 mmol/L. 
On hospital day 3, his bilateral dorsalis pedis, posterior 
tibialis, and left radial pulses were absent. He developed 
areas of ecchymoses on his lower extremities that evolved 
into indurated, well-demarcated purple papules with 
erythematous borders. The patient was diagnosed with 
purpura fulminans given his vascular thromboses and 
disseminated intravascular coagulopathy. He was started 
on clindamycin and given a dose of intravenous immuno-
globulin for presumed toxic shock syndrome secondary to 
GAS bacteremia. His overall status continued to worsen, as 
he developed ischemic limbs, shock liver and worsening 
mental status. Vascular surgery was emergently consulted 
and felt the patient would require amputations of all 
distal extremities if he were to recover hemodynamically. 
On hospital day 5, the patient’s pupils were minimally 
responsive and he had temperatures of 107° F. It was felt 
the patient had a cerebral event and a CT scan of the head 
was ordered. He had a witnessed seizure in the radiology 
department and developed atrial fibrillation that ultimately 
became asystole. No cardiopulmonary resuscitation (CPR) 
was initiated as the patient was made do not resuscitate 
(DNR) by his family. The patient was pronounced dead in 
the MICU, and his family was notified.
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purpura fulminans is associated with Streptococcus 
pneumoniae bacteremia.12 It can also occur in individuals 
with inherited or acquired deficiencies in the Protein C 
or Protein S anticoagulant pathway.13 Purpura fulminans 
is rarely reported in adults with GAS bacteremia who 
have functioning spleens. Purpura fulminans is a severe, 
life-threatening syndrome in which disseminated 
intravascular coagulation (DIC) leads first to hemorrhagic 
skin infarcts and progresses to limb ischemia. When 
purpura fulminans is due to sepsis, the vascular lesions 
causing the classical skin findings also involve a variety of 
organs, including the kidneys, lungs, and adrenal glands. 
The mortality rate associated with purpura fulminans is 
typically greater than 50 percent.11
The pathogenesis of sepsis-induced purpura fulminans 
involves bacterial endotoxin mediated disturbances of 
procoagulant and anticoagulant activities in vascular 
endothelial cells. Anticoagulant factors become widely 
consumed, leading to a state of DIC.14 The initial clinical 
manifestation of purpura fulminans is typically a petechial, 
purpuric rash. Other clinical features include the classical 
manifestations of sepsis, such as fevers and hypotension. 
The characteristic petechial rash typically develops 12-24 
hours after onset of infectious symptoms, which in the 
above patient included shortness of breath and chest 
tightness. As hemorrhagic skin infarction progresses, 
the petechiae coalesce to form purpuric ecchymoses. 
Hemorrhagic bullae can then form and develop into dry 
gangrene.15
Treatment is mainly supportive and also targets the 
bacterial trigger of purpura fulminans.11 The majority of 
affected patients require intensive care unit monitoring 
for aggressive fluid resuscitation, inotropic support, 
mechanical ventilation, and/or hemodialysis. Surgery 
can be performed to debride necrotic tissue, but most 
affected patients eventually require amputations of 
ischemic limbs.16 Various therapies have been proposed 
to target the coagulation pathway deficiencies associated 
with purpura fulminans, but none have showed any 
significant clinical efficacy.11 Recombinant activated 
protein C has been described as a promising adjunctive 
therapy in a number of case studies and retrospective 
studies; however, no randomized controlled trials have 
been performed to demonstrate its effectiveness.17 
dISCuSSIon
GAS is an aerobic gram-positive beta-hemolytic coccus 
that causes an array of diseases in all age groups. In 
patients over the age of forty, risk factors for developing 
GAS bacteremia include burns, surgical procedures, 
trauma, nosocomial transmission, chronic steroid use, 
cardiac disease, diabetes mellitus, peripheral vascular 
disease, malignancy and immunosuppression3,4. Early 
recognition of GAS bacteremia is important to improving 
survival. GAS bacteremia can lead to shock and organ 
failure, such as renal failure, acute respiratory distress 
syndrome, hepatic failure and diffuse capillary leak 
syndrome.1 Streptococcal toxic shock syndrome (TSS) 
can be caused by any streptococcal species, but it is 
most commonly associated with GAS.5 The mortality 
rate for patients with GAS bacteremia is approximately 35 
percent; however once TSS develops, the mortality rate 
is 79 percent.6
In addition to aggressive fluid resuscitation, GAS TSS must 
also be treated with IV antibiotics. GAS is susceptible to 
beta-lactam antibiotics, but there is a high failure rate in 
invasive infections.7 Beta-lactams, such as penicillin G, 
inhibit cell wall synthesis, but can be overwhelmed by 
a large inoculum size. Clindamycin should be added 
to the antibiotic regimen to suppress toxin production 
by inhibiting protein synthesis.8 Intravenous immune 
globulin (IVIG) can also be used as an adjunctive therapy. 
Though data on using IVIG in patients with streptococcal 
TSS is limited, it is believed that IVIG helps by raising 
antibody levels in patients with invasive infections.8 A 
study conducted by Carapetis et al. examined eighty-four 
patients with invasive GAS infections. The primary 
outcome of mortality was compared across patients who 
received clindamycin as a single adjunct versus patients 
who received dual adjunct therapy with clindamycin and 
IVIG.8 Patients treated with clindamycin often had more 
severe disease but lower mortality (15% versus 39%).8 
Patients who received IVIG in addition to clindamycin had 
an even lower mortality rate, at 7%.8 
Our patient presented with common features of GAS 
TSS, including shock and multi-organ failure, as well 
as rarer manifestations, such as purpura fulminans and 
limb ischemia. Purpura fulminans is most commonly 
seen in children with invasive group B beta-hemolytic 
streptococcal infections,9 but it has also been reported 
in association with GAS.10 In adults, purpura fulminans is 
most commonly associated with Neisseria meningitidis, 
followed by streptococcal species.11 In asplenic adults, 
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